Sticko lets drivers put smartphones on windshields
The OrbiMed Israel fund includes an investment provided by the Israeli government, which previous reports have put at $40 million.
US healthcare investment management firm OrbiMed has announced the closing of its first investment fund dedicated to life sciences venture capital opportunities in Israel. The $222 million fund, which will be called the OrbiMed Israel Partners Limited Partnership, includes an investment of provided by the Israel government which previous reports have put at $40 million. Orbimed said that the Israeli government also provided special economic terms through the initial tender process for the Fund.
The Fund is led by three full time Israel-based partners Dr. Nissim Darvish, Anat Naschitz and Erez Chimovits. They will work in close collaboration with Jonathan Silverstein and Carl Gordon, general partners and co-heads of OrbiMed’s global private equity business, and with Aya Jakobovits, a venture partner.
Silverstein said that OrbiMed Israel builds on OrbiMed’s longstanding investment interest in Israel, which has led to many investments there over the past decade, including early-stage investments in Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) and SuperDimension, which was recently acquired by Covidien.
He said, “Israel is known for scientific excellence and entrepreneurial prowess. The Israeli life sciences sector has a strong track record of innovation and commercial success, and presents an opportunity for further growth from what is currently a more mature base. We see increasing maturity in the Israeli industry, as evidenced by two recent acquisitions of revenue-stage companies SuperDimension and Oridion. We also see a significant increase in clinical-stage biopharmaceutical companies.”
OrbiMed Israel senior managing director Dr. Nissim Darvish said, “We are excited about the opportunity to simultaneously create value for our investors and nourish the Israeli life sciences industry by leveraging our global networks and expertise.”
He added that the new fund invests in biotechnology, pharmaceutical, medical device and diagnostics companies at varying stages of maturity, from seed stage through growth equity. The Fund has made two investments already: Keystone Heart, which develops an embolic protection device for interventional cardiology procedures, and Otic Pharma, which develops foam formulations for ear medication.
Published by Globes, Israel business news - www.globes-online.com - on April 23, 2012
© Copyright of Globes Publisher Itonut (1983) Ltd. 2012
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments
Sticko has developed a tiny phone mount for attaching a smartphone to a glass surface.
Two small-cap cos plan Wall Street offerings
Merecot Corp. and Triumph Ventures each plan to raise $100,000.
Data analytics co Fundbox raises $17.5m
Fundbox processes invoices, allowing small businesses to fix their cash flow.
Start-up entrepreneurs are older than you think
A "Globes"-Terra Venture Partners survey found 1,000 start-ups were set up in 2013.
Incubator CEO fled law career for high tech
Esther Barak-Landes left a promising law career to found Nielsen's incubator.
Amazon, Google, Microsoft battle to host developers
The Internet giants want to attract developers to build apps on their cloud-computing infrastructures.
AR: Technology that cares
InfinityAR CIO Helen Papagiannis: Augmented reality will change our world for the better.
JDate founder seeks fresh start
Joe Shapira lost his JDate fortune in US real estate. Now he's back in the dating game.
Dov Moran: Windows 8 deserves to disappear
Moran talks about his investment portfolio, and slams Microsoft's lack of innovation.
"You can't teach entrepreneurship"
Angel investor Zohar Gilon relies on his own judgement rather than due diligence when selecting investments.
Waze CEO: We're completely different from Google
Noam Bardin says Waze is different from Google in how much it trusts users and how it builds data.
Nielsen Innovate recruits first six start-ups
The Nielsen Company has launched its incubator in Caesarea in partnership with Igal Ahouvi.
Wanted: Arts majors for high-tech
Technology companies are looking for creativity, flexibility, and the ability to think outside the box.
2013 boom year for Israeli high-tech
In the first half of the year, there was a 52% rise in demand for mobile and web developers, and salaries are up as well.
Merck Serono Israel incubator nurtures early stage projects
Merck Germany head of pharmaceuticals Dr. Stefan Oschmann says R&D is enjoying a renaissance at big pharma companies.
Alcobra has had two successful Nasdaq offerings this year as it develops an ADHD treatment with fewer side effects.
Israel offers favorable tax regime for companies
"Globes" and Baker Tilly Israel accountants found Israel's tax benefits are among the most attractive in the West.
Enabling diabetes patients to sleep soundly
Excess insulin levels can be fatal when they occur at night. NightSense aims to remove the fear.
CyberArk reboots network security
CEO Udi Mokady: Media reports on electronic surveillance make explaining our product unnecessary.